In vivo pharmacodynamic study of the novel polymyxin MRX-8
- 4 March 2025
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 997, 177423
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Meteorological Sciences (2021-I2M-1-030, 2021-I2M-1-039)
- National Natural Science Foundation of China (32141003, 82330110)
This publication has 12 references indexed in Scilit:
- In Vitro Potency and Spectrum of the Novel Polymyxin MRX-8 Tested against Clinical Isolates of Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2022
- Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitalsMolecular Biology Reports, 2021
- Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative PathogensAntimicrobial Agents and Chemotherapy, 2020
- Synergistic Effect of Colistin Combined with PFK-158 against Colistin-Resistant EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2019
- Re-estimating annual deaths due to multidrug-resistant organism infectionsInfection Control & Hospital Epidemiology, 2018
- Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder FormulationAntimicrobial Agents and Chemotherapy, 2018
- Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection modelsJournal of Antimicrobial Chemotherapy, 2017
- A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studiesJournal of Antimicrobial Chemotherapy, 2013
- In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinoloneJournal of Antimicrobial Chemotherapy, 2010
- Soft drug design: General principles and recent applicationsMedicinal Research Reviews, 2000